Pathologists are helping care team interpret genetic laboratory test results for patients in the cardiac catheterization laboratory
Genetic tests will be part of the regular care protocols for some cardiology patients at both the University of Florida (UF) Clinical and Translational Science Institute (CTSI) and Stanford University Medical Center. Among other factors, it is faster time-to-answer and the lower cost of certain genetic technologies that make it feasible to use genetic tests in this care setting.
In particular, the genetic tests will be used to guide cardiologists as they make therapeutic decisions. Assisting in the interpretation of these tests will be pathologists and clinical laboratory professionals. (more…)
Clinical trial demonstrated value of genetic point-of-care testing and a rapid time to result
Here’s a milestone in genetic testing that should catch the attention of pathologists and clinical laboratory managers everywhere. It is a point-of-care (POC) genetic test that is reliable enough to be used in a clinical trial.
The clinical trial was called RAPID GENE. It was conducted at the University of Ottawa Heart Institute (UOHI). The study enrolled 200 patients who were being treated with cardiac stenting for an acute coronary syndrome or stable angina. What made this study unique is that—for the first time in medicine—it used a point-of-care (POC) genetic test. The genetic POCT was used to overcome many previous obstacles that had prevented use of more routine clinical genetic testing.